New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
When Lisa Ordóñez came to the Rady School of Management to become its new dean on Sept. 1, her arrival at UC San Diego was a homecoming. Although she spent the last 25 years at University of Arizona’s Eller School of Management as an academic researcher and vice dean, Ordóñez earned all three of…
A third occurrence of colon cancer and a failed immunotherapy clinical trial left Gordon Levine confined to a wheelchair with large tumors in his right hip bone, spine and lung, plus smaller tumors throughout his body, including one that caused an obstruction in his colon.
In fiscal year 2019, UC San Diego earned $1.35 billion in sponsored research funding, a 10% increase over the previous year. This is the largest number ever for the university and marks the 10th consecutive year the campus has surpassed the $1 billion mark.
From the stories that emerged during a two-day celebration in honor of Shu Chien’s retirement, it’s clear that he is a beloved mentor who inspired his students, colleagues and collaborators to make the world a better place.
From the world’s largest outdoor earthquake simulator to an international network of seismic stations, UC San Diego is a living laboratory for seismic safety. As an estimated 9.5 million people across the state are set to participate in the Great California ShakeOut earthquake drill today, UC San Diego…
Material scientists have discovered what makes the scales of the massive Amazonian freshwater fish, Arapaima gigas, resistant to breaking when a piranha bites. The answer could serve as inspiration for stronger, lightweight and flexible synthetic armors.
A UC San Diego-led research team has created an interactive map of preterm births and potential environmental and social drivers across Fresno County in central California. A similar map will be unveiled for the San Francisco and Oakland areas October 21.
UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells.
In Fall 2019, the Center for the Future of Surgery at UC San Diego School of Medicine expanded to address the newest surgical trends, especially those benefiting the brain and the nervous system.